Brooklyn FI LLC Buys Shares of 2,752 UnitedHealth Group Incorporated (NYSE:UNH)

Brooklyn FI LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,752 shares of the healthcare conglomerate's stock, valued at approximately $1,392,000.

A number of other hedge funds have also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $25,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $40,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.0 %

UNH traded up $0.09 during trading on Monday, reaching $516.94. The stock had a trading volume of 3,840,856 shares, compared to its average volume of 4,087,242. The stock's 50 day moving average is $510.19 and its two-hundred day moving average is $546.71. The company has a market capitalization of $472.85 billion, a price-to-earnings ratio of 33.35, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.83 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on UNH shares. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research note on Thursday, December 5th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Finally, Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.